While many central banks, such as the US Fed and the Bank of England, are holding off on rate cuts, the Swiss National Bank ...

In a typically quirky Irish way, while Northern Ireland continue to seek out a goalscoring forward who would be the ...

President Martin Schlegel firmly stated that the SNB has no plans to invest in crypto assets, citing their unsuitability for ...

Some European central banking and supervisory officials are questioning whether they can still rely on the U.S. Federal ...

A sea change in German fiscal policy is underfoot with a massive package of fiscal stimulus measures for defense and ...

The US data calendar for the coming week is fairly light, with the Conference Board's consumer confidence on Tuesday as a ...

Everest Reinsurance, part of Bermuda-based Everest Group, has confirmed the appointment of Jason Koh from large European ...

Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research note issued on Thursday.

Adding international stocks to your portfolio is a great way to diversify your investments, particularly in turbulent ...

Investment analysts at William Blair increased their Q2 2025 EPS estimates for shares of Incyte in a research note issued on Tuesday, March 18th. William Blair analyst M. Phipps now expects that the ...

A rally in several tech giants spurred a late-day rebound in US stocks, following a selloff driven by disappointing outlooks ...